The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Nice summary on the respected Techmarketview:
Https://www.techmarketview.com/ukhotviews/archive/2022/01/17/centralnic-ahead-of-expectations-for-the-full-year
"Monday 17 January 2022
CentralNic ahead of expectations for the full year
Full year trading update out this morning from Internet domain name and web services provider CentralNic, points towards strong growth across the board for the Group.
CentralNic’s focus has been to look to rapidly build scale through multiple acquisitions (see its latest here) and organic growth in areas that deliver high recurring revenue and high cash conversion. It is a strategy that continues to serve the company well as it matures as a business, with today’s update outlining expected full year revenues of $410m – an increase of c.70% from the previous financial year.
Acquisitions are also helping drive organic growth which is expected to increase year on year by 37%. Profitability is also moving rapidly in the right direction with adjusted EBITDA expected of around $45m – an increase of 47% from the previous financial year. Cash generation also increased to $55.6m from $28.7m, whilst net debt declined to $76m from $85m, notwithstanding the $19m spent on the acquisitions of Safebrands, Wando and NameAction.
CentralNic has had a good twelve months with results likely to be well above market expectations having already been revised up during the year. Full year results are out on 28th February when we will provide deeper analysis."
GBX 135.87
4.92%
+6.37 Today , not bad
looking for 10% high to open ,nice
Trading ahead of expectations once more....around 5% ahead of forecasts which have already been upgraded multiple times.
Plus debt is heavily reduced despite the acquisitions, on the back of cash convesrion "well in excess of 100%" due to all those lovely annual subscriptions paid in advance.
This should further accelerate the re-rating towards broker targets of 230p-250p:
Https://uk.advfn.com/stock-market/london/centralnic-CNIC/share-news/CentralNic-Group-PLC-Trading-pdate-and-Notice-of/87024826